Rapid Influenza Diagnostic Tests Market Report

Global Rapid Influenza Diagnostic Tests Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：161
  • REPORT CODE：GMM832542
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Rapid Influenza Diagnostic Tests market report explains the definition, types, applications, major countries, and major players of the Rapid Influenza Diagnostic Tests market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sekisui Diagnostics

    • Thermo Fisher Scientific

    • CorisBioconcept

    • Princeton BioMeditech Corporation

    • SA Scientific

    • Alere

    • bioMrieux

    • Quidel

    • Response Biomedical (acquired by OrbiMed)

    • BD

    • Meridian Bioscience

    By Type:

    • Influenza A

    • Influenza B

    By End-User:

    • Hospital

    • Clinic

    • Household

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Rapid Influenza Diagnostic Tests Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Rapid Influenza Diagnostic Tests Outlook to 2028- Original Forecasts

    • 2.2 Rapid Influenza Diagnostic Tests Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Rapid Influenza Diagnostic Tests Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Rapid Influenza Diagnostic Tests Market- Recent Developments

    • 6.1 Rapid Influenza Diagnostic Tests Market News and Developments

    • 6.2 Rapid Influenza Diagnostic Tests Market Deals Landscape

    7 Rapid Influenza Diagnostic Tests Raw Materials and Cost Structure Analysis

    • 7.1 Rapid Influenza Diagnostic Tests Key Raw Materials

    • 7.2 Rapid Influenza Diagnostic Tests Price Trend of Key Raw Materials

    • 7.3 Rapid Influenza Diagnostic Tests Key Suppliers of Raw Materials

    • 7.4 Rapid Influenza Diagnostic Tests Market Concentration Rate of Raw Materials

    • 7.5 Rapid Influenza Diagnostic Tests Cost Structure Analysis

      • 7.5.1 Rapid Influenza Diagnostic Tests Raw Materials Analysis

      • 7.5.2 Rapid Influenza Diagnostic Tests Labor Cost Analysis

      • 7.5.3 Rapid Influenza Diagnostic Tests Manufacturing Expenses Analysis

    8 Global Rapid Influenza Diagnostic Tests Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Rapid Influenza Diagnostic Tests Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Rapid Influenza Diagnostic Tests Export by Region (Top 10 Countries) (2017-2028)

    9 Global Rapid Influenza Diagnostic Tests Market Outlook by Types and Applications to 2022

    • 9.1 Global Rapid Influenza Diagnostic Tests Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Influenza A Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Influenza B Consumption and Growth Rate (2017-2022)

    • 9.2 Global Rapid Influenza Diagnostic Tests Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Household Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Rapid Influenza Diagnostic Tests Market Analysis and Outlook till 2022

    • 10.1 Global Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.2.2 Canada Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.2.3 Mexico Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.2 UK Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.3 Spain Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.4 Belgium Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.5 France Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.6 Italy Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.7 Denmark Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.8 Finland Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.9 Norway Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.10 Sweden Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.11 Poland Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.12 Russia Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.3.13 Turkey Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.2 Japan Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.3 India Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.4 South Korea Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.5 Pakistan Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.6 Bangladesh Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.7 Indonesia Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.8 Thailand Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.9 Singapore Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.10 Malaysia Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.11 Philippines Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.4.12 Vietnam Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.5.2 Colombia Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.5.3 Chile Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.5.4 Argentina Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.5.5 Venezuela Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.5.6 Peru Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.5.7 Puerto Rico Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.5.8 Ecuador Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.6.2 Kuwait Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.6.3 Oman Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.6.4 Qatar Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.7.2 South Africa Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.7.3 Egypt Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.7.4 Algeria Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Rapid Influenza Diagnostic Tests Consumption (2017-2022)

      • 10.8.2 New Zealand Rapid Influenza Diagnostic Tests Consumption (2017-2022)

    11 Global Rapid Influenza Diagnostic Tests Competitive Analysis

    • 11.1 Sekisui Diagnostics

      • 11.1.1 Sekisui Diagnostics Company Details

      • 11.1.2 Sekisui Diagnostics Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sekisui Diagnostics Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.1.4 Sekisui Diagnostics Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Thermo Fisher Scientific

      • 11.2.1 Thermo Fisher Scientific Company Details

      • 11.2.2 Thermo Fisher Scientific Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.2.4 Thermo Fisher Scientific Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 CorisBioconcept

      • 11.3.1 CorisBioconcept Company Details

      • 11.3.2 CorisBioconcept Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 CorisBioconcept Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.3.4 CorisBioconcept Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Princeton BioMeditech Corporation

      • 11.4.1 Princeton BioMeditech Corporation Company Details

      • 11.4.2 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.4.4 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 SA Scientific

      • 11.5.1 SA Scientific Company Details

      • 11.5.2 SA Scientific Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 SA Scientific Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.5.4 SA Scientific Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Alere

      • 11.6.1 Alere Company Details

      • 11.6.2 Alere Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Alere Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.6.4 Alere Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 bioMrieux

      • 11.7.1 bioMrieux Company Details

      • 11.7.2 bioMrieux Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 bioMrieux Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.7.4 bioMrieux Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Quidel

      • 11.8.1 Quidel Company Details

      • 11.8.2 Quidel Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Quidel Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.8.4 Quidel Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Response Biomedical (acquired by OrbiMed)

      • 11.9.1 Response Biomedical (acquired by OrbiMed) Company Details

      • 11.9.2 Response Biomedical (acquired by OrbiMed) Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Response Biomedical (acquired by OrbiMed) Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.9.4 Response Biomedical (acquired by OrbiMed) Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 BD

      • 11.10.1 BD Company Details

      • 11.10.2 BD Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 BD Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.10.4 BD Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Meridian Bioscience

      • 11.11.1 Meridian Bioscience Company Details

      • 11.11.2 Meridian Bioscience Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Meridian Bioscience Rapid Influenza Diagnostic Tests Main Business and Markets Served

      • 11.11.4 Meridian Bioscience Rapid Influenza Diagnostic Tests Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Rapid Influenza Diagnostic Tests Market Outlook by Types and Applications to 2028

    • 12.1 Global Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Influenza A Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Influenza B Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Rapid Influenza Diagnostic Tests Market Analysis and Outlook to 2028

    • 13.1 Global Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.2.2 Canada Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.2 UK Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.3 Spain Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.5 France Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.6 Italy Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.8 Finland Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.9 Norway Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.11 Poland Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.12 Russia Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.2 Japan Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.3 India Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.5.3 Chile Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.5.6 Peru Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.6.3 Oman Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Rapid Influenza Diagnostic Tests Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Rapid Influenza Diagnostic Tests

    • Figure of Rapid Influenza Diagnostic Tests Picture

    • Table Global Rapid Influenza Diagnostic Tests Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Rapid Influenza Diagnostic Tests Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Influenza A Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza B Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Household Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Table North America Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Figure United States Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Canada Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Mexico Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table Europe Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Figure Germany Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure UK Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Spain Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Belgium Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure France Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Italy Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Denmark Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Finland Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Norway Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Sweden Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Poland Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Russia Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Turkey Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table APAC Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Figure China Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Japan Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure India Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure South Korea Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Thailand Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Singapore Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Philippines Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table South America Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Figure Brazil Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Colombia Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Chile Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Argentina Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Peru Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table GCC Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Figure Bahrain Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Oman Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Qatar Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table Africa Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Figure Nigeria Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure South Africa Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Egypt Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Algeria Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table Oceania Rapid Influenza Diagnostic Tests Consumption by Country (2017-2022)

    • Figure Australia Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Rapid Influenza Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table Sekisui Diagnostics Company Details

    • Table Sekisui Diagnostics Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sekisui Diagnostics Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table Sekisui Diagnostics Rapid Influenza Diagnostic Tests Product Portfolio

    • Table Thermo Fisher Scientific Company Details

    • Table Thermo Fisher Scientific Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table Thermo Fisher Scientific Rapid Influenza Diagnostic Tests Product Portfolio

    • Table CorisBioconcept Company Details

    • Table CorisBioconcept Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table CorisBioconcept Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table CorisBioconcept Rapid Influenza Diagnostic Tests Product Portfolio

    • Table Princeton BioMeditech Corporation Company Details

    • Table Princeton BioMeditech Corporation Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Princeton BioMeditech Corporation Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table Princeton BioMeditech Corporation Rapid Influenza Diagnostic Tests Product Portfolio

    • Table SA Scientific Company Details

    • Table SA Scientific Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table SA Scientific Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table SA Scientific Rapid Influenza Diagnostic Tests Product Portfolio

    • Table Alere Company Details

    • Table Alere Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alere Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table Alere Rapid Influenza Diagnostic Tests Product Portfolio

    • Table bioMrieux Company Details

    • Table bioMrieux Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table bioMrieux Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table bioMrieux Rapid Influenza Diagnostic Tests Product Portfolio

    • Table Quidel Company Details

    • Table Quidel Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quidel Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table Quidel Rapid Influenza Diagnostic Tests Product Portfolio

    • Table Response Biomedical (acquired by OrbiMed) Company Details

    • Table Response Biomedical (acquired by OrbiMed) Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Response Biomedical (acquired by OrbiMed) Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table Response Biomedical (acquired by OrbiMed) Rapid Influenza Diagnostic Tests Product Portfolio

    • Table BD Company Details

    • Table BD Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table BD Rapid Influenza Diagnostic Tests Product Portfolio

    • Table Meridian Bioscience Company Details

    • Table Meridian Bioscience Rapid Influenza Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meridian Bioscience Rapid Influenza Diagnostic Tests Main Business and Markets Served

    • Table Meridian Bioscience Rapid Influenza Diagnostic Tests Product Portfolio

    • Figure Global Influenza A Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Household Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Table North America Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure United States Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure Germany Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure China Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure Brazil Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Rapid Influenza Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure Australia Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Rapid Influenza Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US